Income Statement
CAMP4 THERAPEUTICS CORP
CAMP
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Revenue
|
3.50 | 0.65 |
|
Cost of Revenue
|
- | - |
|
Gross Profit
|
3.50 | 0.65 |
|
Operating Expenses
|
56.05 | 53.74 |
|
Research & Development
|
38.20 | 38.82 |
|
Selling, General & Administrative
|
17.36 | 14.92 |
|
Other Operating Expenses
|
- | - |
|
Operating Income
|
-52.56 | -53.09 |
|
Non-Operating Income
|
-27.85 | 1.30 |
|
Interest Income
|
2.17 | 1.33 |
|
Interest Expense
|
- | - |
|
Other Non-Op Income / Expense
|
- | - |
|
Income Before Tax
|
- | - |
|
Income Tax Expense
|
- | - |
|
Non-Controlling Interest
|
- | - |
|
Net Income
|
-80.40 | -51.79 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Depreciation & Amortization
|
- | - |
|
EBITDA
|
-50.92 | -51.39 |
|
Earnings Per Share (Basic)
|
-2.65 | -11.04 |
|
Diluted EPS
|
-2.65 | -11.04 |
|
Weighted Average Shares
|
30.38 | 4.69 |
|
Diluted Weighted Avg Shares
|
30.38 | 4.69 |
|
Comprehensive Income
|
-80.40 | -51.79 |